Advertisements for personalized GLP-1 weight-loss drugs are now as pervasive as they are dangerous. There’s already a robust national debate about direct-to-consumer pharmaceutical advertising.
Advertisements for personalized GLP-1 weight-loss drugs are now as pervasive as they are dangerous. There’s already a robust national debate about direct-to-consumer pharmaceutical advertising.